mPEG-NH2, MW 40K
To Order Contact us: lieven@wlsolutions.be
mPEG-GA,40K |
||
| 33-MF001012-40K |
|
|
|
Description: A high purity chemical with various applications in medical research, drug-release, nanotechnology and new materials research, cell culture. In the study of ligand, polypeptide synthesis support, a graft polymer compounds, new materials, and polyethylene glycol-modified functional coatings and other aspects of the active compound. |
||
mPEG-SA,40K |
||
| 33-MF001013-40K |
|
|
|
Description: A high purity chemical with various applications in medical research, drug-release, nanotechnology and new materials research, cell culture. In the study of ligand, polypeptide synthesis support, a graft polymer compounds, new materials, and polyethylene glycol-modified functional coatings and other aspects of the active compound. |
||
mPEG-SG,40K |
||
| 33-MF001027-40K |
|
|
|
Description: A high purity chemical with various applications in medical research, drug-release, nanotechnology and new materials research, cell culture. In the study of ligand, polypeptide synthesis support, a graft polymer compounds, new materials, and polyethylene glycol-modified functional coatings and other aspects of the active compound. |
||
mPEG-SS,40K |
||
| 33-MF001028-40K |
|
|
|
Description: A high purity chemical with various applications in medical research, drug-release, nanotechnology and new materials research, cell culture. In the study of ligand, polypeptide synthesis support, a graft polymer compounds, new materials, and polyethylene glycol-modified functional coatings and other aspects of the active compound. |
||
mPEG-CHO,40K |
||
| 33-MF001004-40K |
|
|
|
Description: A high purity chemical with various applications in medical research, drug-release, nanotechnology and new materials research, cell culture. In the study of ligand, polypeptide synthesis support, a graft polymer compounds, new materials, and polyethylene glycol-modified functional coatings and other aspects of the active compound. |
||
mPEG-ACA,40K |
||
| 33-MF001010-40K |
|
|
|
Description: A high purity chemical with various applications in medical research, drug-release, nanotechnology and new materials research, cell culture. In the study of ligand, polypeptide synthesis support, a graft polymer compounds, new materials, and polyethylene glycol-modified functional coatings and other aspects of the active compound. |
||
mPEG-GAA,40K |
||
| 33-MF001014-40K |
|
|
|
Description: A high purity chemical with various applications in medical research, drug-release, nanotechnology and new materials research, cell culture. In the study of ligand, polypeptide synthesis support, a graft polymer compounds, new materials, and polyethylene glycol-modified functional coatings and other aspects of the active compound. |
||
mPEG-MAL,40K |
||
| 33-MF001022-40K |
|
|
|
Description: A high purity chemical with various applications in medical research, drug-release, nanotechnology and new materials research, cell culture. In the study of ligand, polypeptide synthesis support, a graft polymer compounds, new materials, and polyethylene glycol-modified functional coatings and other aspects of the active compound. |
||
mPEG-GAS,40K |
||
| 33-MF001029-40K |
|
|
|
Description: A high purity chemical with various applications in medical research, drug-release, nanotechnology and new materials research, cell culture. In the study of ligand, polypeptide synthesis support, a graft polymer compounds, new materials, and polyethylene glycol-modified functional coatings and other aspects of the active compound. |
||
mPEG-SAS,40K |
||
| 33-MF001030-40K |
|
|
|
Description: A high purity chemical with various applications in medical research, drug-release, nanotechnology and new materials research, cell culture. In the study of ligand, polypeptide synthesis support, a graft polymer compounds, new materials, and polyethylene glycol-modified functional coatings and other aspects of the active compound. |
||
mPEG-NPC,40K |
||
| 33-MF001034-40K |
|
|
|
Description: A high purity chemical with various applications in medical research, drug-release, nanotechnology and new materials research, cell culture. In the study of ligand, polypeptide synthesis support, a graft polymer compounds, new materials, and polyethylene glycol-modified functional coatings and other aspects of the active compound. |
||
mPEG-FITC,40K |
||
| FL001044-40K-100mg | 100mg | EUR 475.2 |
|
Description: A high purity chemical with various applications in medical research, drug-release, nanotechnology and new materials research, cell culture. In the study of ligand, polypeptide synthesis support, a graft polymer compounds, new materials, and polyethylene glycol-modified functional coatings and other aspects of the active compound. |
||
mPEG-OPSS,40K |
||
| 33-MF001035-40K |
|
|
|
Description: A high purity chemical with various applications in medical research, drug-release, nanotechnology and new materials research, cell culture. In the study of ligand, polypeptide synthesis support, a graft polymer compounds, new materials, and polyethylene glycol-modified functional coatings and other aspects of the active compound. |
||
mPEG-DSPE,40K |
||
| 33-MF001096-40K |
|
|
|
Description: A high purity chemical with various applications in medical research, drug-release, nanotechnology and new materials research, cell culture. In the study of ligand, polypeptide synthesis support, a graft polymer compounds, new materials, and polyethylene glycol-modified functional coatings and other aspects of the active compound. |
||
mPEG-Biotin,40K |
||
| 33-MF001041-40K |
|
|
|
Description: A high purity chemical with various applications in medical research, drug-release, nanotechnology and new materials research, cell culture. In the study of ligand, polypeptide synthesis support, a graft polymer compounds, new materials, and polyethylene glycol-modified functional coatings and other aspects of the active compound. |
||
mPEG-Epoxide,40K |
||
| 33-MF001021-40K |
|
|
|
Description: A high purity chemical with various applications in medical research, drug-release, nanotechnology and new materials research, cell culture. In the study of ligand, polypeptide synthesis support, a graft polymer compounds, new materials, and polyethylene glycol-modified functional coatings and other aspects of the active compound. |
||
mPEG-Hydrazide,40K |
||
| 33-MF001019-40K |
|
|
|
Description: A high purity chemical with various applications in medical research, drug-release, nanotechnology and new materials research, cell culture. In the study of ligand, polypeptide synthesis support, a graft polymer compounds, new materials, and polyethylene glycol-modified functional coatings and other aspects of the active compound. |
||
mPEG-NH2 |
||
| abx085016-035kDa1g | 0.35 kDa; 1 g | EUR 393.6 |
mPEG-NH2 |
||
| abx085016-055kDa1g | 0.55 kDa; 1 g | EUR 410.4 |
mPEG-NH2 |
||
| abx085016-100l | 100 µl | EUR 250 |
mPEG-NH2 |
||
| abx085016-10kDa1g | 10 kDa; 1 g | EUR 393.6 |
mPEG-NH2 |
||
| abx085016-1ml | 1 ml | EUR 262.5 |
mPEG-NH2 |
||
| abx085016-200l | 200 µl | EUR 262.5 |
mPEG-NH2 |
||
| abx085016-20kDa1g | 20 kDa; 1 g | EUR 393.6 |
mPEG-NH2-HCl |
||
| abx085389-100l | 100 µl | EUR 187.5 |
mPEG-NH2-HCl |
||
| abx085389-1ml | 1 ml | EUR 187.5 |
mPEG-NH2-HCl |
||
| abx085389-200l | 200 µl | EUR 187.5 |
mPEG-NH2-HCl |
||
| abx085389-2kDa1g | 2 kDa; 1 g | EUR 144 |
MPEG-NH2 (Mn= 2,000) |
||
| M745860 | 100mg | EUR 75 |
|
Description: 80506-64-5 |
||
mPEG-NH2?HCl,2K |
||
| 33-MF001050-2K |
|
|
|
Description: A high purity chemical with various applications in medical research, drug-release, nanotechnology and new materials research, cell culture. In the study of ligand, polypeptide synthesis support, a graft polymer compounds, new materials, and polyethylene glycol-modified functional coatings and other aspects of the active compound. |
||
micromer®-MPEG-NH2 |
||
| 08-55-104 | 10µm | EUR 329 |
micromer®-MPEG-NH2 |
||
| 08-55-203 | 2µm | EUR 329 |
micromer®-MPEG-NH2 |
||
| 08-55-303 | 3µm | EUR 329 |
micromer®-MPEG-NH2 |
||
| 08-55-403 | 4µm | EUR 329 |
micromer®-MPEG-NH2 |
||
| 08-55-503 | 5µm | EUR 329 |
micromer®-MPEG-NH2 |
||
| 08-55-603 | 6µm | EUR 329 |
micromer®-MPEG-NH2 |
||
| 08-55-703 | 7µm | EUR 329 |
micromer®-MPEG-NH2 |
||
| 08-55-803 | 8µm | EUR 329 |
mPEG-CHO (MW 350) |
||
| HY-155915 | Get quote | Ask for price |
|
Description: mPEG-CHO (MW 350) participates in the formation of a three-dimensional porous scaffold which carries active substances to form a delivery vehicle. The -CHO functional group interacts with the -NH2 functional group of the chitosan chain to form a glutaraldehyde-type adduct to functionalize mPEG. This functionalization and cross-linking can affect the rigidity of the delivery system, allowing slow release of the cross-linked conjugate system. |
||
mPEG-CHO (MW 550) |
||
| HY-155916 | Get quote | Ask for price |
|
Description: mPEG-CHO (MW 550) participates in the formation of a three-dimensional porous scaffold which carries active substances to form a delivery vehicle. The -CHO functional group interacts with the -NH2 functional group of the chitosan chain to form a glutaraldehyde-type adduct to functionalize mPEG. This functionalization and cross-linking can affect the rigidity of the delivery system, allowing slow release of the cross-linked conjugate system. |
||
mPEG-CHO (MW 750) |
||
| HY-155917 | Get quote | Ask for price |
|
Description: mPEG-CHO (MW 750) participates in the formation of a three-dimensional porous scaffold which carries active substances to form a delivery vehicle. The -CHO functional group interacts with the -NH2 functional group of the chitosan chain to form a glutaraldehyde-type adduct to functionalize mPEG. This functionalization and cross-linking can affect the rigidity of the delivery system, allowing slow release of the cross-linked conjugate system. |
||
mPEG-CHO (MW 1000) |
||
| HY-155918 | Get quote | Ask for price |
|
Description: mPEG-CHO (MW 1000) participates in the formation of a three-dimensional porous scaffold that carries active substances to form a delivery vehicle. The -CHO functional group interacts with the -NH2 functional group of the chitosan chain to form a glutaraldehyde-type adduct to functionalize mPEG. This functionalization and cross-linking can affect the rigidity of the delivery system, allowing slow release of the cross-linked conjugate system. |
||
mPEG-CHO (MW 2000) |
||
| HY-155919 | Get quote | Ask for price |
|
Description: mPEG-CHO (MW 2000) participates in the formation of a three-dimensional porous scaffold which carries active substances to form a delivery vehicle. The -CHO functional group interacts with the -NH2 functional group of the chitosan chain to form a glutaraldehyde-type adduct to functionalize mPEG. This functionalization and cross-linking can affect the rigidity of the delivery system, allowing slow release of the cross-linked conjugate system. |
||
mPEG-CHO (MW 3400) |
||
| HY-155920 | Get quote | Ask for price |
|
Description: mPEG-CHO (MW 3400) participates in the formation of a three-dimensional porous scaffold which carries active substances to form a delivery vehicle. The -CHO functional group interacts with the -NH2 functional group of the chitosan chain to form a glutaraldehyde-type adduct to functionalize mPEG. This functionalization and cross-linking can affect the rigidity of the delivery system, allowing slow release of the cross-linked conjugate system. |
||
mPEG-CHO (MW 5000) |
||
| HY-155921 | Get quote | Ask for price |
|
Description: mPEG-CHO (MW 5000) participates in the formation of a three-dimensional porous scaffold which carries active substances to form a delivery vehicle. The -CHO functional group interacts with the -NH2 functional group of the chitosan chain to form a glutaraldehyde-type adduct to functionalize mPEG. This functionalization and cross-linking can affect the rigidity of the delivery system, allowing slow release of the cross-linked conjugate system. |
||
mPEG-CHO (MW 10000) |
||
| HY-155922 | Get quote | Ask for price |
|
Description: mPEG-CHO (MW 10000) participates in the formation of a three-dimensional porous scaffold which carries active substances to form a delivery vehicle. The -CHO functional group interacts with the -NH2 functional group of the chitosan chain to form a glutaraldehyde-type adduct to functionalize mPEG. This functionalization and cross-linking can affect the rigidity of the delivery system, allowing slow release of the cross-linked conjugate system. |
||
mPEG-CHO (MW 20000) |
||
| HY-155923 | Get quote | Ask for price |
|
Description: mPEG-CHO (MW 20000) participates in the formation of a three-dimensional porous scaffold which carries active substances to form a delivery vehicle. The -CHO functional group interacts with the -NH2 functional group of the chitosan chain to form a glutaraldehyde-type adduct to functionalize mPEG. This functionalization and cross-linking can affect the rigidity of the delivery system, allowing slow release of the cross-linked conjugate system. |
||
mPEG-DSPE, MW 2000 |
||
| HY-139385 | Get quote | Ask for price |
|
Description: mPEG-DSPE, MW 2000 is a phospholipid PEG conjugate, has both hydrophilicity and hydrophobility. mPEG-DSPE, MW 2000 is used in the synthesis of liposomes, increases the hydrophilicity on the surface of liposomes, consequently increasing the longevity of liposomes in the blood circulation for the study of anticancer and antimalarial agents[1][2]. |
||
mPEG-amine (MW 350) |
||
| HY-155880 | Get quote | Ask for price |
|
Description: mPEG-amine (MW 350) can synthesize folate-conjugated polymer micelles for encapsulation of anticancer agent 9-nitrocamptothecin (HY-16560). folate-conjugated polymer micelles are effective carriers of insoluble anticancer drugs, which can avoid macrophages and play a role in endocytosis of tumor cells mediated by folate receptors (FR). |
||
mPEG-amine (MW 550) |
||
| HY-155881 | Get quote | Ask for price |
|
Description: mPEG-amine (MW 550) can synthesize folate-conjugated polymer micelles for encapsulation of anticancer agent 9-nitrocamptothecin (HY-16560). folate-conjugated polymer micelles are effective carriers of insoluble anticancer drugs, which can avoid macrophages and play a role in endocytosis of tumor cells mediated by folate receptors (FR). |
||
mPEG-amine (MW 750) |
||
| HY-155882 | Get quote | Ask for price |
|
Description: mPEG-amine (MW 750) can synthesize folate-conjugated polymer micelles for encapsulation of anticancer agent 9-nitrocamptothecin (HY-16560). folate-conjugated polymer micelles are effective carriers of insoluble anticancer drugs, which can avoid macrophages and play a role in endocytosis of tumor cells mediated by folate receptors (FR). |
||
mPEG-amine (MW 3400) |
||
| HY-155883 | Get quote | Ask for price |
|
Description: mPEG-amine (MW 3400) can synthesize folate-conjugated polymer micelles for encapsulation of anticancer agent 9-nitrocamptothecin (HY-16560). folate-conjugated polymer micelles are effective carriers of insoluble anticancer drugs, which can avoid macrophages and play a role in endocytosis of tumor cells mediated by folate receptors (FR). |
||
mPEG-amine (MW 4000) |
||
| HY-155884 | Get quote | Ask for price |
|
Description: mPEG-amine (MW 4000) can be used to synthesize folate-conjugated polymer micelles for encapsulating anticancer agent 9-nitrocamptothecin (HY-16560). folate-conjugated polymer micelles are effective carriers of insoluble anticancer drugs, which can avoid macrophages and play a role in endocytosis of tumor cells mediated by folate receptors (FR). |
||
mPEG-amine (MW 1000) |
||
| HY-140675 | 100 mg | EUR 140.69 |
|
Description: m-PEG-NH2 (MW 1000) is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs[1]. |
||
mPEG-amine (MW 2000) |
||
| HY-140676 | 100mg | Ask for price |
|
Description: mPEG-amine (mPEG-NH2) (MW 2000) is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs[1]. |
||
mPEG-amine (MW 5000) |
||
| HY-140677 | 100mg | Ask for price |
|
Description: mPEG-amine (mPEG-NH2) (MW 5000) is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs[1]. |
||
mPEG-amine (MW 10000) |
||
| HY-140678 | Get quote | Ask for price |
|
Description: mPEG-amine (mPEG-NH2) (MW 10000) is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs[1]. |
||
mPEG-amine (MW 20000) |
||
| HY-140679 | 100 mg | EUR 37.88 |
|
Description: m-PEG-NH2 (MW 20000) is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs[1]. |
||
mPEG-Biotinylated (MW: 5000) |
||
| PEG-BTN | 1 mg | EUR 416.4 |
mPEG-DSPE, MW 2000 (sodium) |
||
| HY-139385A | 100 mg | EUR 54.11 |
|
Description: mPEG-DSPE, MW 2000 sodium is a phospholipid PEG conjugate, has both hydrophilicity and hydrophobility. mPEG-DSPE, MW 2000 sodium is used in the synthesis of liposomes, increases the hydrophilicity on the surface of liposomes, consequently increasing the longevity of liposomes in the blood circulation for the study of anticancer and antimalarial agents[1][2]. |
||
MPEG-PLA (PEG MW 3000 & PLA MW 50,000) |
||
| HY-139819 | 100 mg | EUR 97.4 |
|
Description: MPEG-PLA (PEG MW 3000 & PLA MW 50,000) is a block copolymer, which can be used to preparenanoparticles for targeted drug delivery[1]. |
||
m-PEG-NH2 (MW 1000) |
||
| T18097-10mg | 10mg | Ask for price |
|
Description: m-PEG-NH2 (MW 1000) |
||
m-PEG-NH2 (MW 1000) |
||
| T18097-1g | 1g | Ask for price |
|
Description: m-PEG-NH2 (MW 1000) |
||
m-PEG-NH2 (MW 1000) |
||
| T18097-1mg | 1mg | Ask for price |
|
Description: m-PEG-NH2 (MW 1000) |
||
m-PEG-NH2 (MW 1000) |
||
| T18097-50mg | 50mg | Ask for price |
|
Description: m-PEG-NH2 (MW 1000) |
||
m-PEG-NH2 (MW 1000) |
||
| T18097-5mg | 5mg | Ask for price |
|
Description: m-PEG-NH2 (MW 1000) |
||
m-PEG-NH2 (MW 10000) |
||
| T18098-10mg | 10mg | Ask for price |
|
Description: m-PEG-NH2 (MW 10000) |
||
m-PEG-NH2 (MW 10000) |
||
| T18098-1g | 1g | Ask for price |
|
Description: m-PEG-NH2 (MW 10000) |
||
m-PEG-NH2 (MW 10000) |
||
| T18098-1mg | 1mg | Ask for price |
|
Description: m-PEG-NH2 (MW 10000) |
||
m-PEG-NH2 (MW 10000) |
||
| T18098-50mg | 50mg | Ask for price |
|
Description: m-PEG-NH2 (MW 10000) |
||
m-PEG-NH2 (MW 10000) |
||
| T18098-5mg | 5mg | Ask for price |
|
Description: m-PEG-NH2 (MW 10000) |
||
m-PEG-NH2 (MW 2000) |
||
| T18099-10mg | 10mg | Ask for price |
|
Description: m-PEG-NH2 (MW 2000) |
||
m-PEG-NH2 (MW 2000) |
||
| T18099-1g | 1g | Ask for price |
|
Description: m-PEG-NH2 (MW 2000) |
||
m-PEG-NH2 (MW 2000) |
||
| T18099-1mg | 1mg | Ask for price |
|
Description: m-PEG-NH2 (MW 2000) |
||
m-PEG-NH2 (MW 2000) |
||
| T18099-50mg | 50mg | Ask for price |
|
Description: m-PEG-NH2 (MW 2000) |
||
m-PEG-NH2 (MW 2000) |
||
| T18099-5mg | 5mg | Ask for price |
|
Description: m-PEG-NH2 (MW 2000) |
||
m-PEG-NH2 (MW 20000) |
||
| T18100-10mg | 10mg | Ask for price |
|
Description: m-PEG-NH2 (MW 20000) |
||
m-PEG-NH2 (MW 20000) |
||
| T18100-1g | 1g | Ask for price |
|
Description: m-PEG-NH2 (MW 20000) |
||
m-PEG-NH2 (MW 20000) |
||
| T18100-1mg | 1mg | Ask for price |
|
Description: m-PEG-NH2 (MW 20000) |
||
m-PEG-NH2 (MW 20000) |
||
| T18100-50mg | 50mg | Ask for price |
|
Description: m-PEG-NH2 (MW 20000) |
||
m-PEG-NH2 (MW 20000) |
||
| T18100-5mg | 5mg | Ask for price |
|
Description: m-PEG-NH2 (MW 20000) |
||
m-PEG-NH2 (MW 5000) |
||
| T18101-10mg | 10mg | Ask for price |
|
Description: m-PEG-NH2 (MW 5000) |
||
m-PEG-NH2 (MW 5000) |
||
| T18101-1g | 1g | Ask for price |
|
Description: m-PEG-NH2 (MW 5000) |
||
m-PEG-NH2 (MW 5000) |
||
| T18101-1mg | 1mg | Ask for price |
|
Description: m-PEG-NH2 (MW 5000) |
||
m-PEG-NH2 (MW 5000) |
||
| T18101-50mg | 50mg | Ask for price |
|
Description: m-PEG-NH2 (MW 5000) |
||